From left: Mike Birtwistle, Sarah Winstone and Bill Morgan
Incisive Health has opened its first office outside the UK on the back of a rapid expansion in its international business.
The London-headquartered policy and communications consultancy’s new Brussels office – home to its Incisive Health International arm – is located at Square de Meeûs 35, in the heart of the city’s European Quarter.
Founding partner Sarah Winstone said: “Tried and tested quickly becomes tested but tired. Clients have been telling us that international health policy communications needs a shake-up. Incisive Health’s approach is tailor-made to do precisely that.”
The move comes in the wake of Incisive’s international project work for the likes of 23andMe, AbbVie, EFPIA, the Global Lung Cancer Coalition, Norgine and Roche.
Formed in 2013 by founding partners Mike Birtwistle, Bill Morgan and Sarah Winstone, Incisive Health has since grow into a 21-strong team whose work includes pan-European and global health issues.
Birtwistle said: “The world of health policy is getting smaller and contact with key decision-makers has never been easier. But getting cut-through is more challenging. We founded Incisive Health precisely because we know how to achieve this.”
The agency’s expansion plans have also seen it recently appoint Anna Dé as head of international business development to help accelerate its growth.
She joined Incisive in January from Ogilvy Healthworld Market Access, where she spent three years as associate managing partner, prior she held senior roles at Acumen and Hill+Knowlton Strategies.